like the effects observed in many tissue systems, TGF-f3 does not invariably inhibit the mitogenic response of bone cells to other growth promoters. In contrast, other factors such as epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), and type a tumor necrosis factor (TNF-a) limit the response of osteoblastic bone cells to TGF-13. TGF-j3 is a much weaker mitogen for fibroblastic cells obtained from fetal rat bone, whereas fetal bovine serum, EGF, bFGF, and TNF-cr are more potent stimulators.
In addition, TGF-/3 does not significantly impair the response of the fibroblastic bone cells to the other tested agents. These findings reinforce a role of TGF-f3 as an anabolic bone growth regulator, and suggest that its function may be modified by other local or systemic agents that can also affect bone 
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13-, 16-, and 5-fold, respectively (Fig. 4) The mitogenic effect of the same concentration of each agent, tested in the absence of TGF-13, is shown in Fig. 1 . 
